FDA approves new tuberculosis drug
Washington: US Food and Drug Administration (USFDA) on Monday approved Johnson & Johnson`s drug for treating multidrug-resistant tuberculosis - the first such federal approval aimed at tackling the deadly disease in 40 years.
The drug named Sirturo - known chemically as bedaquilineas – is an alternative treatment for adults suffering from TB when two more powerful medications that are available, isoniazid and rifampicin, do not work, FDA said. However the regulator cautioned that the new drug should be used sparingly.
The FDA said Sirturo will carry a boxed warning to alert patients and health professionals that the drug can affect the heart`s electrical activity, which could lead to an abnormal and potentially fatal heart rhythm. The warning also noted deaths in patients treated with Sirturo and that nine patients who received Sirturo died -- compared with two patients who received a placebo.
TB is an infection caused by Mycobacterium tuberculosis and is one of the world`s deadliest diseases. It is spread from person to person through the air and usually affects the lungs, but it can also affect other parts of the body such as the brain and kidneys.
With Agency Inputs
More from India
More from World
More from Sports
More from Entertaiment
- Congress workers blow up pigeons by blasting them inside rockets
- Beef row: Lalu Prasad Yadav contradicts his statements
- Lalu Yadav's son Tejasvi Yadav wants to change the face of Bihar education
- Indian Army 5th deadliest in the world: Report
- Indrani Mukerjea attains consciousness; is now out of danger
- Indrani Mukerjea regains consciousness, out of danger, says hospital
- Is Salman Khan - Aamir Khan friendship over?
- Dadri lynching case: Sadhvi Prachi makes provocative remark, says beef-eaters deserve such fate
- Modi must be punished, he has cheated people: Ram Jethmalani
- Was Giani Zail Singh planning to topple Rajiv Gandhi govt in 1987?